Delivery Order SPE2DB20D2104-SPE2DB24FR17C
- Not listed
- This federal contract award is for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $1,982.95 and a completion date of May 3, 2024. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent...
- This federal contract award is for the delivery of Vyvanse capsules (30mg) to the Defense Logistics Agency (DLA), which is a component of the Department of Defense. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a total ceiling value of $4,465.39 and is a Firm Fixed Price Delivery Order with an ultimate completion date of January 17, 2023. The contract was awarded on January 16, 2023 and does not have...
- The federal contract award is for the delivery of Vyvanse capsules, 30mg, to the Defense Logistics Agency (DLA). The $16,721.57 fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of June 4, 2025 and is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $8,688.04, is a delivery order awarded under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a potential value of up to $999,999,999 and runs through November 2026. This IDC serves as the primary...
- This federal contract award is for the delivery of Vyvanse 30 mg capsules in 100-count packages to the Defense Logistics Agency (DLA). The $9,748.40 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on October 21, 2024, with an ultimate completion date of October 22, 2024. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award is for the delivery of Vyvanse capsules 30mg to the Defense Logistics Agency (DLA) Troop Support Medical. The contract was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The one-year contract has a ceiling value of $8,332.56 and is a firm-fixed-price delivery order. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp...
- This federal contract award is for the delivery of Vyvanse capsules (40mg) to the Defense Logistics Agency (DLA), a defense agency. The $34,466.34 firm-fixed-price delivery order contract has a period of performance through May 28, 2025. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is not set aside and was awarded through open competition. Amerisourcebergen Drug Corp holds a larger $999,999,999.00...
- This federal contract award is for the delivery of Vyvanse 60 mg capsules in 100-count bottles to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price of $4,328.30 and a completion date of December 18, 2024. The contract is not designated with any set-aside requirements, indicating open competition. Amerisourcebergen Drug Corp holds...
- This federal contract award is for the delivery of Vyvanse 20 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,081.35, is a delivery order awarded under an Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical. This IDC, valued at up to $999,999,999.00, serves as the...
- This federal contract award is for the delivery of Vyvanse 50 mg capsules to the Defense Logistics Agency (DLA), a defense agency. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on March 24, 2025 for a ceiling value of $4,906.88. It is a delivery order contract with a firm fixed price pricing type, and the ultimate completion date is March 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite...
- SPE2DB20D2104Indefinite Delivery Contract
- SPE2DB20D2104-SPE2DB24FR17CDelivery Order
This federal contract award is for the delivery of Vyvanse 30 mg capsules to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $3,010.59 and an ultimate completion date of November 15, 2023. It is a delivery order contract with a firm fixed price pricing type. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which also holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, for the delivery of a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 11/14/23 |